COVID‐19 and Pregnancy: A Case Study

The 2019 novel coronavirus disease is spreading all over the world. Pregnant women and infants require particular concern, owing to the special immune conditions. A case of a pregnant woman who was exposed to SARS‐CoV‐2 at 34+1 weeks gestation and chose to continue pregnancy is reported. Without obvious symptoms or signs, the woman did not receive any treatment before delivery, and gave birth at 37+5 weeks to a neonate with positive immunoglobulin G for SARS‐CoV‐2 and negative nucleic acid tests. The mother was given anti‐infection, oxytocin, and fluid rehydration treatment after delivery. Both mother and infant recovered well after a three‐month follow‐up. Continued expectation to deliver at term instead of preterm can decrease the potential risk of severe perinatal and infant complications and is beneficial to the development of the neonate. More studies are required to confirm the presence of vertical transmission.
A case study of a pregnant woman who was exposed to SARS‐CoV‐2 at 34+1 weeks gestation and continued expectation until 37+5 weeks with a healthy neonate is reported.